Administrative Core
行政核心
基本信息
- 批准号:10507629
- 负责人:
- 金额:$ 200.29万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:AdherenceAdoptedAgingAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAmyloidAncillary StudyBudgetsCognitiveCollaborationsDevelopmentDiabetes MellitusEducationEnsureFundingGoalsInstitutional Review BoardsJournalsLeadershipLigandsLogisticsManuscriptsMeasurableMentorshipMinorityMonitorNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute on AgingNon-Insulin-Dependent Diabetes MellitusObservational StudyOutcomeOutcome StudyParticipantPeer ReviewPrediabetes syndromePreparationPrevention GuidelinesPrevention programPrincipal InvestigatorProceduresProgress ReportsProtocols documentationPublicationsReadingReportingResearchResearch PersonnelResourcesScientistSiteStructureTravelUnited StatesUnited States Centers for Medicare and Medicaid ServicesUniversitiesUpdateWashingtonbasecareer developmentclinical centerclinical research sitedata sharingdiabetes prevention programeducation researchexperiencemeetingsprogramssuccessweb siteworking group
项目摘要
The goal of the Administrative Core is to provide budgetary and administrative support to the other 4 cores and
4 projects in the Diabetes Prevention Program Outcomes Study (DPPOS) Alzheimer’s Disease (AD)/AD related
dementias (ADRD) Project. The Administrative Core will support the governance structure of the DPPOS
AD/ADRD Project, and will interact with leadership at the National Institute on Aging (NIA) and other national AD
and ADRD research and research education programs. The DPPOS has a well-developed organization that has
conducted ground-breaking research in pre-diabetes (preD) and type 2 diabetes (T2D) over more than 25 years,
supporting 25 clinical sites and multiple reading centers across the United States. The success of this
organization is best reflected by the high level of retention of clinical centers and participants; assiduous
adherence to the study protocol; hundreds of publications in high impact journals; and the development of T2D
prevention guidelines and programs based on DPPOS findings that have been adopted widely, including by the
Center for Medicaid and Medicare Services. The DPPOS working committees and subcommittees will remain
largely intact, with the AD/ADRD Project’s Executive Committee, Steering committee, Publications and
Presentations Committee, and Ancillary Studies Committee continuing into the proposed funding period under
the Administrative Core. The leadership of the Administrative Core will be the same as for the overall project
using a multiple principal investigator (PI) arrangement, shared by PIs Luchsinger, Nathan, and Temprosa. PI
Nathan has been the chair of the DPPOS since its inception. PI Temprosa has been the leader of the DPPOS
coordinating center based at George Washington University. Contact PI Luchsinger has led the Cognitive
Coordinating Center of DPPOS since 2009, has co-led its Working Group on Aging, and has led NIA funded
AD/ADRD research and education programs for 20 years. The Administrative Core (AC) will achieve its goals
through the following specific aims: (1). Support the governance structure of the proposed U19; (2) Support all
cores and projects logistically and financially; (3) Ensure administrative and regulatory compliance; (4) Support
dissemination and collaboration; (5) Support mentorship and career development in T2D and AD/ADRD
research; (6) To evaluate the success of the proposed research program through measurable goals and
outcomes.
行政核心的目标是为其他4个核心提供预算和行政支持,
糖尿病预防计划结果研究(DPPOS)阿尔茨海默氏病(AD)/AD相关的4个项目
痴呆症(ADRD)项目。行政核心将支持DPPO的治理结构
AD/ADRD项目,并将与国家老化研究所(NIA)和其他国家广告的领导层互动
和ADRD研究与研究教育计划。 DPPO有一个发达的组织,
在超过25年中,对糖尿病前(PREP)和2型糖尿病(T2D)进行了突破性研究,
在美国支持25个临床站点和多个阅读中心。这个成功
组织的高度保留量最能反映出临床中心和参与者。协助
遵守研究方案;高影响期刊的数百份出版物;以及T2D的发展
根据已广泛通过的DPPO调查结果的预防准则和计划,包括
医疗补助和医疗保险服务中心。 DPPO的工作委员会和小组委员会将继续
广告/ADRD项目的执行委员会,指导委员会,出版物和
演讲委员会和辅助研究委员会继续进入拟议的资金期限
行政核心。行政核心的领导将与整个项目相同
使用Pis Luchsinger,Nathan和Temprosa共享的多个主要研究员(PI)安排。 pi
内森(Nathan)自成立以来就一直是DPPO的主席。 Pi Temprosa一直是DPPO的领导者
位于乔治华盛顿大学的协调中心。联系Pi Luchsinger领导了认知
自2009年以来,DPPO的协调中心已共同领导其老龄化工作组,并领导了NIA资助
AD/ADRD研究和教育计划已有20年。行政核心(AC)将实现其目标
通过以下特定目的:(1)。支持拟议的U19的治理结构; (2)支持全部
核心和项目在逻辑和财务上; (3)确保行政和监管合规性; (4)支持
传播与协作; (5)在T2D和AD/ADRD中支持Mentalship和职业发展
研究; (6)通过可衡量的目标和
结果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jose Alejandro Luchsinger其他文献
Jose Alejandro Luchsinger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jose Alejandro Luchsinger', 18)}}的其他基金
Midcareer Award for Research in Dementia Risk Factors and Prevention
痴呆症风险因素和预防研究职业中期奖
- 批准号:
10645176 - 财政年份:2022
- 资助金额:
$ 200.29万 - 项目类别:
DPPOS AD/ADRD Health Economics Evaluation
DPPOS AD/ADRD 健康经济学评估
- 批准号:
10702144 - 财政年份:2022
- 资助金额:
$ 200.29万 - 项目类别:
Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project
糖尿病前期和 2 型糖尿病中的阿尔茨海默病和阿尔茨海默病相关痴呆:糖尿病预防计划成果研究 AD/ADRD 项目
- 批准号:
10901549 - 财政年份:2022
- 资助金额:
$ 200.29万 - 项目类别:
Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project
糖尿病前期和 2 型糖尿病中的阿尔茨海默病和阿尔茨海默病相关痴呆:糖尿病预防计划成果研究 AD/ADRD 项目
- 批准号:
10507628 - 财政年份:2022
- 资助金额:
$ 200.29万 - 项目类别:
Association of cumulative exposure to metformin and other T2D medications with cognitive impairment and AD/ADRD biomarkers
二甲双胍和其他 T2D 药物累积暴露与认知障碍和 AD/ADRD 生物标志物的关联
- 批准号:
10507636 - 财政年份:2022
- 资助金额:
$ 200.29万 - 项目类别:
Midcareer Award for Research in Dementia Risk Factors and Prevention
痴呆症风险因素和预防研究职业中期奖
- 批准号:
10457636 - 财政年份:2022
- 资助金额:
$ 200.29万 - 项目类别:
Measurement and estimation of lucidity prevalence in persons with dementia and neurological disorders
痴呆和神经系统疾病患者清醒率的测量和估计
- 批准号:
10091724 - 财政年份:2020
- 资助金额:
$ 200.29万 - 项目类别:
Measurement and estimation of lucidity prevalence in persons with dementia and neurological disorders
痴呆和神经系统疾病患者清醒率的测量和估计
- 批准号:
10688736 - 财政年份:2020
- 资助金额:
$ 200.29万 - 项目类别:
相似国自然基金
采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
- 批准号:32371047
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
破解老年人数字鸿沟:老年人采用数字技术的决策过程、客观障碍和应对策略
- 批准号:72303205
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
通过抑制流体运动和采用双能谱方法来改进烧蚀速率测量的研究
- 批准号:12305261
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
采用多种稀疏自注意力机制的Transformer隧道衬砌裂缝检测方法研究
- 批准号:62301339
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
政策激励、信息传递与农户屋顶光伏技术采用提升机制研究
- 批准号:72304103
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Exercise adherence and cognitive decline: Engaging with the Black community to develop and test a goal-setting and exercise intensity intervention
运动坚持和认知能力下降:与黑人社区合作制定和测试目标设定和运动强度干预措施
- 批准号:
10767102 - 财政年份:2023
- 资助金额:
$ 200.29万 - 项目类别:
Gamma-Music Based Intervention for Mild Alzheimer's Disease
基于伽玛音乐的轻度阿尔茨海默病干预
- 批准号:
10703506 - 财政年份:2022
- 资助金额:
$ 200.29万 - 项目类别:
Web-based technology and cognitive training: improving executive control in cognitivelyhealthy older adults
基于网络的技术和认知训练:改善认知健康老年人的执行控制
- 批准号:
10682616 - 财政年份:2022
- 资助金额:
$ 200.29万 - 项目类别: